Yasemin Ünver
Yasemin Ünver publishes mostly in Organic Chemistry, Molecular Biology and Inorganic Chemistry, on topics such as Synthesis and biological activity, Synthesis and Characterization of Heterocyclic Compounds and Click Chemistry and Applications.
- World rank
- #7,524,931 of 7,710,434 ranked researchers
- Rank in Türkiye
- #110,143 of 117,622
- Works
- 155
- Citations
- 1.5k
- Citations per work
- 9.8
What does Yasemin Ünver research?
Yasemin Ünver's work is mostly in Chemistry (63%), Materials Science (8%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences11071.0%
- Chemistry9863.4%
- Materials Science127.6%
- Everything else3220.6%
- Life Sciences95.7%
- Health Sciences42.7%
- Medicine42.7%
- 1Organic Chemistry59% of their works
- 2Molecular Biology6% of their works
- 3Inorganic Chemistry4% of their works
- 4Electronic, Optical and Magnetic Materials4% of their works
- 5Materials Chemistry4% of their works
- 6Oncology3% of their works
Research topics
- Synthesis and biological activity
- Synthesis and Characterization of Heterocyclic Compounds
- Click Chemistry and Applications
- Synthesis and Biological Evaluation
- Nonlinear Optical Materials Research
- Crystal structures of chemical compounds
- Porphyrin and Phthalocyanine Chemistry
- Metal complexes synthesis and properties
Which keywords describe Yasemin Ünver's research?
The keywords of their largest research topics: Anticancer Agents, Heterocyclic Compounds, Medicinal Chemistry, Drug Discovery, Tubulin Inhibitors, Vascular Targeting Agents, Biological Evaluation and Synthesis.
- Platinum-Based Drugs
- Porphyrins
- Hirshfeld Surface Analysis
- Nonlinear Optical Materials
- Quinoxaline
- Copper-Catalyzed Cycloaddition
- Metal Complexes
- Triazines
- Synthesis
- Vascular Targeting Agents
- Drug Discovery
- Heterocyclic Compounds
- Anticancer Agents
- Medicinal Chemistry
- Tubulin Inhibitors
- Biological Evaluation
- Antimicrobial
- Crystal Growth
- Click Chemistry
- Antimicrobial Activity
- Computational Chemistry
- Crystal Structure Refinement
- Phthalocyanines
- Cisplatin Resistance
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 24 words, with their numbers
- Anticancer Agents1083 topics
- Heterocyclic Compounds982 topics
- Medicinal Chemistry982 topics
- Drug Discovery832 topics
- Tubulin Inhibitors821 topic
- Vascular Targeting Agents821 topic
- Biological Evaluation812 topics
- Synthesis812 topics
- Antimicrobial651 topic
- Triazines651 topic
- Crystal Growth232 topics
- Metal Complexes212 topics
- Click Chemistry181 topic
- Copper-Catalyzed Cycloaddition181 topic
- Antimicrobial Activity161 topic
- Quinoxaline161 topic
- Computational Chemistry121 topic
- Nonlinear Optical Materials121 topic
- Crystal Structure Refinement111 topic
- Hirshfeld Surface Analysis111 topic
- Phthalocyanines111 topic
- Porphyrins111 topic
- Cisplatin Resistance101 topic
- Platinum-Based Drugs101 topic
Where does Yasemin Ünver work?
Yasemin Ünver's main affiliation in the publication record is Karadeniz Technical University, Türkiye.
How many publications and citations does Yasemin Ünver have?
OpenAlex counts 155 works and 1,520 citations for Yasemin Ünver, an h-index of 22, ranking #7,524,931 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Yasemin Ünver. Posts are plain text and can be reported.